nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—HTR2B—Raloxifene—osteoporosis	0.278	0.437	CbGbCtD
Agomelatine—CYP1A2—Estropipate—osteoporosis	0.0987	0.155	CbGbCtD
Agomelatine—CYP2C9—Estropipate—osteoporosis	0.0889	0.14	CbGbCtD
Agomelatine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0467	0.0734	CbGbCtD
Agomelatine—CYP2C9—Cholecalciferol—osteoporosis	0.0458	0.072	CbGbCtD
Agomelatine—CYP1A2—Estradiol—osteoporosis	0.041	0.0644	CbGbCtD
Agomelatine—CYP2C9—Estradiol—osteoporosis	0.0369	0.0581	CbGbCtD
Agomelatine—Melatonin—CYP19A1—osteoporosis	0.00111	0.521	CrCbGaD
Agomelatine—Melatonin—ESR1—osteoporosis	0.00102	0.479	CrCbGaD
Agomelatine—Nervous system disorder—Ibandronate—osteoporosis	0.000765	0.00282	CcSEcCtD
Agomelatine—Back pain—Risedronate—osteoporosis	0.000762	0.00281	CcSEcCtD
Agomelatine—Hyperhidrosis—Raloxifene—osteoporosis	0.000761	0.00281	CcSEcCtD
Agomelatine—Skin disorder—Ibandronate—osteoporosis	0.000757	0.0028	CcSEcCtD
Agomelatine—Influenza—Estradiol—osteoporosis	0.000756	0.00279	CcSEcCtD
Agomelatine—Hyperhidrosis—Ibandronate—osteoporosis	0.000754	0.00278	CcSEcCtD
Agomelatine—Nausea—Ergocalciferol—osteoporosis	0.000751	0.00277	CcSEcCtD
Agomelatine—Urticaria—Etidronic acid—osteoporosis	0.000747	0.00276	CcSEcCtD
Agomelatine—Abdominal pain—Etidronic acid—osteoporosis	0.000743	0.00274	CcSEcCtD
Agomelatine—Skin disorder—Calcitriol—osteoporosis	0.000741	0.00274	CcSEcCtD
Agomelatine—Angioedema—Ethinyl Estradiol—osteoporosis	0.000738	0.00273	CcSEcCtD
Agomelatine—Insomnia—Estropipate—osteoporosis	0.000735	0.00272	CcSEcCtD
Agomelatine—Eye disorder—Zoledronate—osteoporosis	0.000734	0.00271	CcSEcCtD
Agomelatine—Paraesthesia—Estropipate—osteoporosis	0.00073	0.0027	CcSEcCtD
Agomelatine—Back pain—Pamidronate—osteoporosis	0.000724	0.00267	CcSEcCtD
Agomelatine—Somnolence—Estropipate—osteoporosis	0.000723	0.00267	CcSEcCtD
Agomelatine—Angioedema—Risedronate—osteoporosis	0.00072	0.00266	CcSEcCtD
Agomelatine—Dyspepsia—Estropipate—osteoporosis	0.000716	0.00264	CcSEcCtD
Agomelatine—Insomnia—Raloxifene—osteoporosis	0.000712	0.00263	CcSEcCtD
Agomelatine—Vertigo—Risedronate—osteoporosis	0.000707	0.00261	CcSEcCtD
Agomelatine—Eye disorder—Conjugated Estrogens—osteoporosis	0.000707	0.00261	CcSEcCtD
Agomelatine—Insomnia—Ibandronate—osteoporosis	0.000705	0.00261	CcSEcCtD
Agomelatine—Dyspepsia—Alendronate—osteoporosis	0.000705	0.0026	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Estropipate—osteoporosis	0.000702	0.00259	CcSEcCtD
Agomelatine—Fatigue—Estropipate—osteoporosis	0.000701	0.00259	CcSEcCtD
Agomelatine—Paraesthesia—Ibandronate—osteoporosis	0.0007	0.00259	CcSEcCtD
Agomelatine—Constipation—Estropipate—osteoporosis	0.000695	0.00257	CcSEcCtD
Agomelatine—Dyspepsia—Raloxifene—osteoporosis	0.000693	0.00256	CcSEcCtD
Agomelatine—Insomnia—Calcitriol—osteoporosis	0.00069	0.00255	CcSEcCtD
Agomelatine—Weight increased—Estradiol—osteoporosis	0.000688	0.00254	CcSEcCtD
Agomelatine—Mental disorder—Zoledronate—osteoporosis	0.000688	0.00254	CcSEcCtD
Agomelatine—Agitation—Pamidronate—osteoporosis	0.000688	0.00254	CcSEcCtD
Agomelatine—Dyspepsia—Ibandronate—osteoporosis	0.000686	0.00254	CcSEcCtD
Agomelatine—Anxiety—Ethinyl Estradiol—osteoporosis	0.000685	0.00253	CcSEcCtD
Agomelatine—Constipation—Alendronate—osteoporosis	0.000685	0.00253	CcSEcCtD
Agomelatine—Weight decreased—Estradiol—osteoporosis	0.000684	0.00253	CcSEcCtD
Agomelatine—Angioedema—Pamidronate—osteoporosis	0.000684	0.00253	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000683	0.00252	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00068	0.00251	CcSEcCtD
Agomelatine—Somnolence—Calcitriol—osteoporosis	0.000679	0.00251	CcSEcCtD
Agomelatine—Infestation NOS—Estradiol—osteoporosis	0.000674	0.00249	CcSEcCtD
Agomelatine—Infestation—Estradiol—osteoporosis	0.000674	0.00249	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000673	0.00249	CcSEcCtD
Agomelatine—Depression—Estradiol—osteoporosis	0.000672	0.00248	CcSEcCtD
Agomelatine—Fatigue—Ibandronate—osteoporosis	0.000672	0.00248	CcSEcCtD
Agomelatine—Anxiety—Risedronate—osteoporosis	0.000668	0.00247	CcSEcCtD
Agomelatine—Constipation—Ibandronate—osteoporosis	0.000667	0.00246	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000666	0.00246	CcSEcCtD
Agomelatine—Pruritus—Etidronic acid—osteoporosis	0.000665	0.00246	CcSEcCtD
Agomelatine—Gastrointestinal pain—Estropipate—osteoporosis	0.000665	0.00246	CcSEcCtD
Agomelatine—Mental disorder—Conjugated Estrogens—osteoporosis	0.000663	0.00245	CcSEcCtD
Agomelatine—Back pain—Zoledronate—osteoporosis	0.000661	0.00244	CcSEcCtD
Agomelatine—Jaundice—Estradiol—osteoporosis	0.000657	0.00243	CcSEcCtD
Agomelatine—Dry mouth—Risedronate—osteoporosis	0.000656	0.00242	CcSEcCtD
Agomelatine—Gastrointestinal pain—Alendronate—osteoporosis	0.000655	0.00242	CcSEcCtD
Agomelatine—Infection—Ethinyl Estradiol—osteoporosis	0.000655	0.00242	CcSEcCtD
Agomelatine—Constipation—Calcitriol—osteoporosis	0.000653	0.00241	CcSEcCtD
Agomelatine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000646	0.00239	CcSEcCtD
Agomelatine—Urticaria—Estropipate—osteoporosis	0.000646	0.00239	CcSEcCtD
Agomelatine—Vision blurred—Zoledronate—osteoporosis	0.000644	0.00238	CcSEcCtD
Agomelatine—Gastrointestinal pain—Raloxifene—osteoporosis	0.000644	0.00238	CcSEcCtD
Agomelatine—Diarrhoea—Etidronic acid—osteoporosis	0.000643	0.00238	CcSEcCtD
Agomelatine—Abdominal pain—Estropipate—osteoporosis	0.000643	0.00237	CcSEcCtD
Agomelatine—Tremor—Zoledronate—osteoporosis	0.000641	0.00237	CcSEcCtD
Agomelatine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00064	0.00236	CcSEcCtD
Agomelatine—Infection—Risedronate—osteoporosis	0.000638	0.00236	CcSEcCtD
Agomelatine—Hepatobiliary disease—Estradiol—osteoporosis	0.000638	0.00236	CcSEcCtD
Agomelatine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000638	0.00236	CcSEcCtD
Agomelatine—Back pain—Conjugated Estrogens—osteoporosis	0.000637	0.00235	CcSEcCtD
Agomelatine—Urticaria—Alendronate—osteoporosis	0.000636	0.00235	CcSEcCtD
Agomelatine—Anxiety—Pamidronate—osteoporosis	0.000635	0.00235	CcSEcCtD
Agomelatine—Abdominal pain—Alendronate—osteoporosis	0.000633	0.00234	CcSEcCtD
Agomelatine—Nervous system disorder—Risedronate—osteoporosis	0.00063	0.00233	CcSEcCtD
Agomelatine—Agitation—Zoledronate—osteoporosis	0.000628	0.00232	CcSEcCtD
Agomelatine—Angioedema—Zoledronate—osteoporosis	0.000625	0.00231	CcSEcCtD
Agomelatine—Skin disorder—Risedronate—osteoporosis	0.000624	0.00231	CcSEcCtD
Agomelatine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000624	0.00231	CcSEcCtD
Agomelatine—Abdominal pain—Raloxifene—osteoporosis	0.000623	0.0023	CcSEcCtD
Agomelatine—Vision blurred—Conjugated Estrogens—osteoporosis	0.00062	0.00229	CcSEcCtD
Agomelatine—Urticaria—Ibandronate—osteoporosis	0.000619	0.00229	CcSEcCtD
Agomelatine—Abdominal pain—Ibandronate—osteoporosis	0.000616	0.00228	CcSEcCtD
Agomelatine—Vertigo—Zoledronate—osteoporosis	0.000614	0.00227	CcSEcCtD
Agomelatine—Infection—Pamidronate—osteoporosis	0.000607	0.00224	CcSEcCtD
Agomelatine—Urticaria—Calcitriol—osteoporosis	0.000606	0.00224	CcSEcCtD
Agomelatine—Hepatitis—Estradiol—osteoporosis	0.000605	0.00224	CcSEcCtD
Agomelatine—Abdominal pain—Calcitriol—osteoporosis	0.000603	0.00223	CcSEcCtD
Agomelatine—Angioedema—Conjugated Estrogens—osteoporosis	0.000602	0.00222	CcSEcCtD
Agomelatine—Nervous system disorder—Pamidronate—osteoporosis	0.000599	0.00221	CcSEcCtD
Agomelatine—Vomiting—Etidronic acid—osteoporosis	0.000598	0.00221	CcSEcCtD
Agomelatine—Connective tissue disorder—Estradiol—osteoporosis	0.000595	0.0022	CcSEcCtD
Agomelatine—Vertigo—Conjugated Estrogens—osteoporosis	0.000592	0.00218	CcSEcCtD
Agomelatine—Hyperhidrosis—Pamidronate—osteoporosis	0.000591	0.00218	CcSEcCtD
Agomelatine—Headache—Etidronic acid—osteoporosis	0.000589	0.00218	CcSEcCtD
Agomelatine—Asthenia—Estropipate—osteoporosis	0.000583	0.00216	CcSEcCtD
Agomelatine—Insomnia—Risedronate—osteoporosis	0.000581	0.00215	CcSEcCtD
Agomelatine—Anxiety—Zoledronate—osteoporosis	0.00058	0.00214	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000578	0.00214	CcSEcCtD
Agomelatine—Paraesthesia—Risedronate—osteoporosis	0.000577	0.00213	CcSEcCtD
Agomelatine—Pruritus—Estropipate—osteoporosis	0.000575	0.00213	CcSEcCtD
Agomelatine—Asthenia—Alendronate—osteoporosis	0.000575	0.00212	CcSEcCtD
Agomelatine—Dry mouth—Zoledronate—osteoporosis	0.000569	0.0021	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000569	0.0021	CcSEcCtD
Agomelatine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000568	0.0021	CcSEcCtD
Agomelatine—Pruritus—Alendronate—osteoporosis	0.000567	0.00209	CcSEcCtD
Agomelatine—Dyspepsia—Risedronate—osteoporosis	0.000566	0.00209	CcSEcCtD
Agomelatine—Eye disorder—Estradiol—osteoporosis	0.000566	0.00209	CcSEcCtD
Agomelatine—Tinnitus—Estradiol—osteoporosis	0.000564	0.00208	CcSEcCtD
Agomelatine—Constipation—Ethinyl Estradiol—osteoporosis	0.000564	0.00208	CcSEcCtD
Agomelatine—Asthenia—Ibandronate—osteoporosis	0.000559	0.00207	CcSEcCtD
Agomelatine—Anxiety—Conjugated Estrogens—osteoporosis	0.000559	0.00206	CcSEcCtD
Agomelatine—Nausea—Etidronic acid—osteoporosis	0.000558	0.00206	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000557	0.00206	CcSEcCtD
Agomelatine—Diarrhoea—Estropipate—osteoporosis	0.000556	0.00206	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000555	0.00205	CcSEcCtD
Agomelatine—Infection—Zoledronate—osteoporosis	0.000554	0.00205	CcSEcCtD
Agomelatine—Fatigue—Risedronate—osteoporosis	0.000554	0.00205	CcSEcCtD
Agomelatine—Insomnia—Pamidronate—osteoporosis	0.000553	0.00204	CcSEcCtD
Agomelatine—Pruritus—Ibandronate—osteoporosis	0.000552	0.00204	CcSEcCtD
Agomelatine—Constipation—Risedronate—osteoporosis	0.00055	0.00203	CcSEcCtD
Agomelatine—Paraesthesia—Pamidronate—osteoporosis	0.000549	0.00203	CcSEcCtD
Agomelatine—Diarrhoea—Alendronate—osteoporosis	0.000548	0.00202	CcSEcCtD
Agomelatine—Asthenia—Calcitriol—osteoporosis	0.000548	0.00202	CcSEcCtD
Agomelatine—Nervous system disorder—Zoledronate—osteoporosis	0.000547	0.00202	CcSEcCtD
Agomelatine—Somnolence—Pamidronate—osteoporosis	0.000543	0.00201	CcSEcCtD
Agomelatine—Skin disorder—Zoledronate—osteoporosis	0.000542	0.002	CcSEcCtD
Agomelatine—Pruritus—Calcitriol—osteoporosis	0.00054	0.00199	CcSEcCtD
Agomelatine—Hyperhidrosis—Zoledronate—osteoporosis	0.000539	0.00199	CcSEcCtD
Agomelatine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000539	0.00199	CcSEcCtD
Agomelatine—Diarrhoea—Raloxifene—osteoporosis	0.000539	0.00199	CcSEcCtD
Agomelatine—Dyspepsia—Pamidronate—osteoporosis	0.000538	0.00199	CcSEcCtD
Agomelatine—Dizziness—Estropipate—osteoporosis	0.000538	0.00199	CcSEcCtD
Agomelatine—Infection—Conjugated Estrogens—osteoporosis	0.000534	0.00197	CcSEcCtD
Agomelatine—Diarrhoea—Ibandronate—osteoporosis	0.000534	0.00197	CcSEcCtD
Agomelatine—Mental disorder—Estradiol—osteoporosis	0.00053	0.00196	CcSEcCtD
Agomelatine—Dizziness—Alendronate—osteoporosis	0.00053	0.00196	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000527	0.00195	CcSEcCtD
Agomelatine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000527	0.00195	CcSEcCtD
Agomelatine—Fatigue—Pamidronate—osteoporosis	0.000527	0.00195	CcSEcCtD
Agomelatine—Gastrointestinal pain—Risedronate—osteoporosis	0.000526	0.00194	CcSEcCtD
Agomelatine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000524	0.00193	CcSEcCtD
Agomelatine—Constipation—Pamidronate—osteoporosis	0.000522	0.00193	CcSEcCtD
Agomelatine—Diarrhoea—Calcitriol—osteoporosis	0.000522	0.00193	CcSEcCtD
Agomelatine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000522	0.00193	CcSEcCtD
Agomelatine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000521	0.00192	CcSEcCtD
Agomelatine—Dizziness—Raloxifene—osteoporosis	0.000521	0.00192	CcSEcCtD
Agomelatine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000519	0.00192	CcSEcCtD
Agomelatine—Vomiting—Estropipate—osteoporosis	0.000517	0.00191	CcSEcCtD
Agomelatine—Dizziness—Ibandronate—osteoporosis	0.000516	0.0019	CcSEcCtD
Agomelatine—Urticaria—Risedronate—osteoporosis	0.000511	0.00189	CcSEcCtD
Agomelatine—Back pain—Estradiol—osteoporosis	0.00051	0.00188	CcSEcCtD
Agomelatine—Headache—Estropipate—osteoporosis	0.000509	0.00188	CcSEcCtD
Agomelatine—Vomiting—Alendronate—osteoporosis	0.000509	0.00188	CcSEcCtD
Agomelatine—Abdominal pain—Risedronate—osteoporosis	0.000508	0.00188	CcSEcCtD
Agomelatine—Insomnia—Zoledronate—osteoporosis	0.000505	0.00186	CcSEcCtD
Agomelatine—Headache—Alendronate—osteoporosis	0.000502	0.00185	CcSEcCtD
Agomelatine—Paraesthesia—Zoledronate—osteoporosis	0.000501	0.00185	CcSEcCtD
Agomelatine—Vomiting—Raloxifene—osteoporosis	0.000501	0.00185	CcSEcCtD
Agomelatine—Gastrointestinal pain—Pamidronate—osteoporosis	0.0005	0.00185	CcSEcCtD
Agomelatine—Somnolence—Zoledronate—osteoporosis	0.000496	0.00183	CcSEcCtD
Agomelatine—Vomiting—Ibandronate—osteoporosis	0.000496	0.00183	CcSEcCtD
Agomelatine—Tremor—Estradiol—osteoporosis	0.000494	0.00182	CcSEcCtD
Agomelatine—Headache—Raloxifene—osteoporosis	0.000493	0.00182	CcSEcCtD
Agomelatine—Dyspepsia—Zoledronate—osteoporosis	0.000491	0.00181	CcSEcCtD
Agomelatine—Headache—Ibandronate—osteoporosis	0.000489	0.0018	CcSEcCtD
Agomelatine—Insomnia—Conjugated Estrogens—osteoporosis	0.000486	0.0018	CcSEcCtD
Agomelatine—Vomiting—Calcitriol—osteoporosis	0.000485	0.00179	CcSEcCtD
Agomelatine—Agitation—Estradiol—osteoporosis	0.000484	0.00179	CcSEcCtD
Agomelatine—Nausea—Estropipate—osteoporosis	0.000483	0.00178	CcSEcCtD
Agomelatine—Abdominal pain—Pamidronate—osteoporosis	0.000483	0.00178	CcSEcCtD
Agomelatine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000482	0.00178	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000482	0.00178	CcSEcCtD
Agomelatine—Angioedema—Estradiol—osteoporosis	0.000481	0.00178	CcSEcCtD
Agomelatine—Fatigue—Zoledronate—osteoporosis	0.000481	0.00178	CcSEcCtD
Agomelatine—Headache—Calcitriol—osteoporosis	0.000478	0.00177	CcSEcCtD
Agomelatine—Somnolence—Conjugated Estrogens—osteoporosis	0.000478	0.00176	CcSEcCtD
Agomelatine—Constipation—Zoledronate—osteoporosis	0.000477	0.00176	CcSEcCtD
Agomelatine—Nausea—Alendronate—osteoporosis	0.000476	0.00176	CcSEcCtD
Agomelatine—Vertigo—Estradiol—osteoporosis	0.000473	0.00175	CcSEcCtD
Agomelatine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000473	0.00175	CcSEcCtD
Agomelatine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000473	0.00175	CcSEcCtD
Agomelatine—Nausea—Raloxifene—osteoporosis	0.000468	0.00173	CcSEcCtD
Agomelatine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000466	0.00172	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000464	0.00171	CcSEcCtD
Agomelatine—Fatigue—Conjugated Estrogens—osteoporosis	0.000463	0.00171	CcSEcCtD
Agomelatine—Nausea—Ibandronate—osteoporosis	0.000463	0.00171	CcSEcCtD
Agomelatine—Asthenia—Risedronate—osteoporosis	0.000461	0.0017	CcSEcCtD
Agomelatine—Constipation—Conjugated Estrogens—osteoporosis	0.000459	0.0017	CcSEcCtD
Agomelatine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000456	0.00169	CcSEcCtD
Agomelatine—Pruritus—Risedronate—osteoporosis	0.000455	0.00168	CcSEcCtD
Agomelatine—Nausea—Calcitriol—osteoporosis	0.000453	0.00167	CcSEcCtD
Agomelatine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000451	0.00167	CcSEcCtD
Agomelatine—Anxiety—Estradiol—osteoporosis	0.000447	0.00165	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000446	0.00165	CcSEcCtD
Agomelatine—Urticaria—Zoledronate—osteoporosis	0.000443	0.00164	CcSEcCtD
Agomelatine—Abdominal pain—Zoledronate—osteoporosis	0.000441	0.00163	CcSEcCtD
Agomelatine—Diarrhoea—Risedronate—osteoporosis	0.00044	0.00162	CcSEcCtD
Agomelatine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000439	0.00162	CcSEcCtD
Agomelatine—Dry mouth—Estradiol—osteoporosis	0.000439	0.00162	CcSEcCtD
Agomelatine—Asthenia—Pamidronate—osteoporosis	0.000438	0.00162	CcSEcCtD
Agomelatine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000436	0.00161	CcSEcCtD
Agomelatine—Pruritus—Pamidronate—osteoporosis	0.000432	0.0016	CcSEcCtD
Agomelatine—Infection—Estradiol—osteoporosis	0.000427	0.00158	CcSEcCtD
Agomelatine—Urticaria—Conjugated Estrogens—osteoporosis	0.000427	0.00158	CcSEcCtD
Agomelatine—Dizziness—Risedronate—osteoporosis	0.000425	0.00157	CcSEcCtD
Agomelatine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000425	0.00157	CcSEcCtD
Agomelatine—Nervous system disorder—Estradiol—osteoporosis	0.000422	0.00156	CcSEcCtD
Agomelatine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000419	0.00155	CcSEcCtD
Agomelatine—Diarrhoea—Pamidronate—osteoporosis	0.000418	0.00154	CcSEcCtD
Agomelatine—Skin disorder—Estradiol—osteoporosis	0.000418	0.00154	CcSEcCtD
Agomelatine—Hyperhidrosis—Estradiol—osteoporosis	0.000416	0.00154	CcSEcCtD
Agomelatine—Headache—Ethinyl Estradiol—osteoporosis	0.000413	0.00153	CcSEcCtD
Agomelatine—Vomiting—Risedronate—osteoporosis	0.000409	0.00151	CcSEcCtD
Agomelatine—Dizziness—Pamidronate—osteoporosis	0.000404	0.00149	CcSEcCtD
Agomelatine—Headache—Risedronate—osteoporosis	0.000403	0.00149	CcSEcCtD
Agomelatine—Asthenia—Zoledronate—osteoporosis	0.0004	0.00148	CcSEcCtD
Agomelatine—Pruritus—Zoledronate—osteoporosis	0.000395	0.00146	CcSEcCtD
Agomelatine—Nausea—Ethinyl Estradiol—osteoporosis	0.000392	0.00145	CcSEcCtD
Agomelatine—Insomnia—Estradiol—osteoporosis	0.000389	0.00144	CcSEcCtD
Agomelatine—Vomiting—Pamidronate—osteoporosis	0.000388	0.00143	CcSEcCtD
Agomelatine—Paraesthesia—Estradiol—osteoporosis	0.000386	0.00143	CcSEcCtD
Agomelatine—Asthenia—Conjugated Estrogens—osteoporosis	0.000386	0.00142	CcSEcCtD
Agomelatine—Headache—Pamidronate—osteoporosis	0.000383	0.00141	CcSEcCtD
Agomelatine—Somnolence—Estradiol—osteoporosis	0.000382	0.00141	CcSEcCtD
Agomelatine—Diarrhoea—Zoledronate—osteoporosis	0.000382	0.00141	CcSEcCtD
Agomelatine—Nausea—Risedronate—osteoporosis	0.000382	0.00141	CcSEcCtD
Agomelatine—Pruritus—Conjugated Estrogens—osteoporosis	0.00038	0.0014	CcSEcCtD
Agomelatine—Dyspepsia—Estradiol—osteoporosis	0.000379	0.0014	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000371	0.00137	CcSEcCtD
Agomelatine—Fatigue—Estradiol—osteoporosis	0.000371	0.00137	CcSEcCtD
Agomelatine—Dizziness—Zoledronate—osteoporosis	0.000369	0.00136	CcSEcCtD
Agomelatine—Constipation—Estradiol—osteoporosis	0.000368	0.00136	CcSEcCtD
Agomelatine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000368	0.00136	CcSEcCtD
Agomelatine—Nausea—Pamidronate—osteoporosis	0.000363	0.00134	CcSEcCtD
Agomelatine—Dizziness—Conjugated Estrogens—osteoporosis	0.000355	0.00131	CcSEcCtD
Agomelatine—Vomiting—Zoledronate—osteoporosis	0.000355	0.00131	CcSEcCtD
Agomelatine—Gastrointestinal pain—Estradiol—osteoporosis	0.000352	0.0013	CcSEcCtD
Agomelatine—Headache—Zoledronate—osteoporosis	0.00035	0.00129	CcSEcCtD
Agomelatine—Vomiting—Conjugated Estrogens—osteoporosis	0.000342	0.00126	CcSEcCtD
Agomelatine—Urticaria—Estradiol—osteoporosis	0.000342	0.00126	CcSEcCtD
Agomelatine—Abdominal pain—Estradiol—osteoporosis	0.00034	0.00126	CcSEcCtD
Agomelatine—Headache—Conjugated Estrogens—osteoporosis	0.000337	0.00124	CcSEcCtD
Agomelatine—Nausea—Zoledronate—osteoporosis	0.000331	0.00122	CcSEcCtD
Agomelatine—Nausea—Conjugated Estrogens—osteoporosis	0.000319	0.00118	CcSEcCtD
Agomelatine—Asthenia—Estradiol—osteoporosis	0.000309	0.00114	CcSEcCtD
Agomelatine—Pruritus—Estradiol—osteoporosis	0.000304	0.00112	CcSEcCtD
Agomelatine—Diarrhoea—Estradiol—osteoporosis	0.000294	0.00109	CcSEcCtD
Agomelatine—Dizziness—Estradiol—osteoporosis	0.000284	0.00105	CcSEcCtD
Agomelatine—Vomiting—Estradiol—osteoporosis	0.000273	0.00101	CcSEcCtD
Agomelatine—Headache—Estradiol—osteoporosis	0.000269	0.000995	CcSEcCtD
Agomelatine—Nausea—Estradiol—osteoporosis	0.000255	0.000944	CcSEcCtD
Agomelatine—HTR2B—GPCR downstream signaling—MGLL—osteoporosis	0.000167	0.00184	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—FGA—osteoporosis	0.000164	0.0018	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—FGA—osteoporosis	0.000164	0.0018	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—PTHLH—osteoporosis	0.000162	0.00178	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—ADCY5—osteoporosis	0.000161	0.00177	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—ADCY5—osteoporosis	0.000161	0.00177	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—PTH—osteoporosis	0.000158	0.00173	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CALCR—osteoporosis	0.000154	0.00169	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PTH1R—osteoporosis	0.000154	0.00169	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CNR2—osteoporosis	0.000154	0.00169	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PTHLH—osteoporosis	0.000152	0.00167	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PTHLH—osteoporosis	0.000152	0.00167	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—BMP2—osteoporosis	0.000152	0.00167	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—BMP2—osteoporosis	0.000152	0.00167	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—MGLL—osteoporosis	0.000152	0.00167	CbGpPWpGaD
Agomelatine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000151	0.00166	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—FGB—osteoporosis	0.000149	0.00164	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—FGB—osteoporosis	0.000149	0.00164	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—WNT1—osteoporosis	0.000145	0.00159	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PSMA5—osteoporosis	0.000144	0.00158	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PSMA2—osteoporosis	0.000144	0.00158	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PSMA5—osteoporosis	0.000144	0.00158	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PSMA2—osteoporosis	0.000144	0.00158	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CALCA—osteoporosis	0.000143	0.00157	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000138	0.00152	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—MGLL—osteoporosis	0.000135	0.00148	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CALCA—osteoporosis	0.000134	0.00147	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CALCA—osteoporosis	0.000134	0.00147	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000131	0.00144	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—PTHLH—osteoporosis	0.000131	0.00144	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—POMC—osteoporosis	0.000131	0.00144	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—POMC—osteoporosis	0.000131	0.00144	CbGpPWpGaD
Agomelatine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000129	0.00142	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000129	0.00142	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SOST—osteoporosis	0.000125	0.00137	CbGpPWpGaD
Agomelatine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000123	0.00135	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—MGLL—osteoporosis	0.000122	0.00135	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—KL—osteoporosis	0.000122	0.00134	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—KL—osteoporosis	0.000122	0.00134	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000119	0.0013	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—POMC—osteoporosis	0.000119	0.0013	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—POMC—osteoporosis	0.000119	0.0013	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000118	0.0013	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL6R—osteoporosis	0.000116	0.00127	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—IL6R—osteoporosis	0.000116	0.00127	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CALCA—osteoporosis	0.000115	0.00126	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CALCR—osteoporosis	0.000113	0.00124	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTH1R—osteoporosis	0.000113	0.00124	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000112	0.00123	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PTH—osteoporosis	0.00011	0.00121	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	0.000108	0.00119	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CNR2—osteoporosis	0.000108	0.00118	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	0.000107	0.00118	CbGpPWpGaD
Agomelatine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000105	0.00115	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000104	0.00114	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000102	0.00112	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SOST—osteoporosis	0.000101	0.00111	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PTH—osteoporosis	0.0001	0.0011	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	9.91e-05	0.00109	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	9.8e-05	0.00108	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CNR2—osteoporosis	9.78e-05	0.00107	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ADCY5—osteoporosis	9.53e-05	0.00105	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ADCY5—osteoporosis	9.53e-05	0.00105	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	9.26e-05	0.00102	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	9.24e-05	0.00102	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	9.22e-05	0.00101	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SPP1—osteoporosis	9.22e-05	0.00101	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SPP1—osteoporosis	9.22e-05	0.00101	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—WNT1—osteoporosis	9.19e-05	0.00101	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PTHLH—osteoporosis	9.15e-05	0.00101	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	9.13e-05	0.001	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CALCR—osteoporosis	9.1e-05	0.001	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTH1R—osteoporosis	9.1e-05	0.001	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MGLL—osteoporosis	8.96e-05	0.000985	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PTH—osteoporosis	8.91e-05	0.00098	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LRP5—osteoporosis	8.75e-05	0.000962	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	8.69e-05	0.000955	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CNR2—osteoporosis	8.69e-05	0.000955	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	8.61e-05	0.000946	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	8.61e-05	0.000946	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	8.47e-05	0.000931	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LRP6—osteoporosis	8.37e-05	0.00092	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IRS2—osteoporosis	8.33e-05	0.000916	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IRS2—osteoporosis	8.33e-05	0.000916	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PTHLH—osteoporosis	8.31e-05	0.000914	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—LEP—osteoporosis	8.16e-05	0.000897	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—LEP—osteoporosis	8.16e-05	0.000897	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PTH—osteoporosis	8.09e-05	0.00089	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CALCA—osteoporosis	8.06e-05	0.000886	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.92e-05	0.000871	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	7.9e-05	0.000869	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CNR2—osteoporosis	7.89e-05	0.000867	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ESR1—osteoporosis	7.79e-05	0.000856	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ESR1—osteoporosis	7.79e-05	0.000856	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—POMC—osteoporosis	7.46e-05	0.00082	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—WNT1—osteoporosis	7.42e-05	0.000815	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PTHLH—osteoporosis	7.39e-05	0.000812	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CALCA—osteoporosis	7.32e-05	0.000805	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IRS1—osteoporosis	7.28e-05	0.0008	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IRS1—osteoporosis	7.28e-05	0.0008	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MGLL—osteoporosis	7.23e-05	0.000795	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TLN1—osteoporosis	7.06e-05	0.000777	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LRP5—osteoporosis	7.06e-05	0.000776	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—POMC—osteoporosis	7.01e-05	0.00077	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—POMC—osteoporosis	7.01e-05	0.00077	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL6R—osteoporosis	6.84e-05	0.000751	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL6R—osteoporosis	6.84e-05	0.000751	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.77e-05	0.000744	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LRP6—osteoporosis	6.75e-05	0.000742	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IGF1—osteoporosis	6.74e-05	0.000741	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IGF1—osteoporosis	6.74e-05	0.000741	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.74e-05	0.000741	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PTHLH—osteoporosis	6.71e-05	0.000737	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—POMC—osteoporosis	6.51e-05	0.000716	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CALCA—osteoporosis	6.5e-05	0.000715	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PKM—osteoporosis	6.14e-05	0.000675	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—FDPS—osteoporosis	6.14e-05	0.000675	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—P4HB—osteoporosis	6.09e-05	0.00067	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—POMC—osteoporosis	6.02e-05	0.000662	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTH—osteoporosis	5.93e-05	0.000652	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CALCA—osteoporosis	5.9e-05	0.000649	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RAP1A—osteoporosis	5.82e-05	0.00064	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GPD2—osteoporosis	5.82e-05	0.00064	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PGLS—osteoporosis	5.82e-05	0.00064	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CNR2—osteoporosis	5.78e-05	0.000635	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.76e-05	0.000633	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	5.75e-05	0.000632	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—ADCY5—osteoporosis	5.73e-05	0.00063	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TLN1—osteoporosis	5.7e-05	0.000627	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NFATC1—osteoporosis	5.68e-05	0.000625	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DKK1—osteoporosis	5.64e-05	0.00062	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—POMC—osteoporosis	5.57e-05	0.000612	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—WNT1—osteoporosis	5.43e-05	0.000597	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ATIC—osteoporosis	5.33e-05	0.000586	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PNP—osteoporosis	5.33e-05	0.000586	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FGA—osteoporosis	5.28e-05	0.000581	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PKM—osteoporosis	5.25e-05	0.000577	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—FDPS—osteoporosis	5.25e-05	0.000577	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—ADCY5—osteoporosis	5.21e-05	0.000572	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—IL6—osteoporosis	5.15e-05	0.000567	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL6—osteoporosis	5.15e-05	0.000567	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GPD2—osteoporosis	4.98e-05	0.000547	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PGLS—osteoporosis	4.98e-05	0.000547	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—P4HB—osteoporosis	4.91e-05	0.00054	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—BMP2—osteoporosis	4.91e-05	0.00054	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTHLH—osteoporosis	4.91e-05	0.00054	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FGB—osteoporosis	4.81e-05	0.000528	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTH—osteoporosis	4.78e-05	0.000526	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RAP1A—osteoporosis	4.7e-05	0.000517	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CNR2—osteoporosis	4.66e-05	0.000512	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PSMA5—osteoporosis	4.64e-05	0.00051	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PSMA2—osteoporosis	4.64e-05	0.00051	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.64e-05	0.00051	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—ADCY5—osteoporosis	4.62e-05	0.000508	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NFATC1—osteoporosis	4.58e-05	0.000504	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ATIC—osteoporosis	4.55e-05	0.0005	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PNP—osteoporosis	4.55e-05	0.0005	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DKK1—osteoporosis	4.55e-05	0.0005	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CA2—osteoporosis	4.53e-05	0.000498	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—OXCT1—osteoporosis	4.53e-05	0.000498	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MGLL—osteoporosis	4.41e-05	0.000485	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—WNT1—osteoporosis	4.38e-05	0.000482	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CALCA—osteoporosis	4.32e-05	0.000475	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FGA—osteoporosis	4.26e-05	0.000469	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—POMC—osteoporosis	4.22e-05	0.000464	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ADCY5—osteoporosis	4.2e-05	0.000462	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.16e-05	0.000458	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MYC—osteoporosis	4.05e-05	0.000445	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MYC—osteoporosis	4.05e-05	0.000445	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TGFB1—osteoporosis	4.04e-05	0.000444	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TGFB1—osteoporosis	4.04e-05	0.000444	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTHLH—osteoporosis	3.96e-05	0.000436	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—BMP2—osteoporosis	3.96e-05	0.000436	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—KL—osteoporosis	3.93e-05	0.000432	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FGB—osteoporosis	3.88e-05	0.000426	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—OXCT1—osteoporosis	3.87e-05	0.000425	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CA2—osteoporosis	3.87e-05	0.000425	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—POMC—osteoporosis	3.83e-05	0.000421	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MGLL—osteoporosis	3.77e-05	0.000415	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—IDH2—osteoporosis	3.75e-05	0.000413	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PSMA2—osteoporosis	3.74e-05	0.000411	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PSMA5—osteoporosis	3.74e-05	0.000411	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6R—osteoporosis	3.74e-05	0.000411	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.56e-05	0.000391	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP27A1—osteoporosis	3.53e-05	0.000388	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CALCA—osteoporosis	3.49e-05	0.000383	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ACP5—osteoporosis	3.43e-05	0.000377	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—POMC—osteoporosis	3.4e-05	0.000374	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.39e-05	0.000373	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—IDH2—osteoporosis	3.21e-05	0.000353	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TPI1—osteoporosis	3.19e-05	0.000351	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KL—osteoporosis	3.17e-05	0.000348	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—POMC—osteoporosis	3.09e-05	0.00034	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADCY5—osteoporosis	3.08e-05	0.000338	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL6—osteoporosis	3.04e-05	0.000335	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL6—osteoporosis	3.04e-05	0.000335	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP27A1—osteoporosis	3.01e-05	0.000331	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6R—osteoporosis	3.01e-05	0.000331	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—P4HB—osteoporosis	3e-05	0.00033	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SPP1—osteoporosis	2.98e-05	0.000327	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GAPDH—osteoporosis	2.94e-05	0.000324	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ACP5—osteoporosis	2.93e-05	0.000322	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.9e-05	0.000318	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—RAP1A—osteoporosis	2.87e-05	0.000315	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TPI1—osteoporosis	2.73e-05	0.0003	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IRS2—osteoporosis	2.69e-05	0.000296	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LEP—osteoporosis	2.63e-05	0.000289	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—P4HB—osteoporosis	2.56e-05	0.000282	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GAPDH—osteoporosis	2.52e-05	0.000277	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ESR1—osteoporosis	2.51e-05	0.000276	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.5e-05	0.000275	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	2.48e-05	0.000273	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—RAP1A—osteoporosis	2.45e-05	0.000269	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SPP1—osteoporosis	2.4e-05	0.000264	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IRS1—osteoporosis	2.35e-05	0.000258	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ENO1—osteoporosis	2.32e-05	0.000255	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PSMA2—osteoporosis	2.28e-05	0.000251	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PSMA5—osteoporosis	2.28e-05	0.000251	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—POMC—osteoporosis	2.26e-05	0.000249	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6R—osteoporosis	2.21e-05	0.000243	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF1—osteoporosis	2.18e-05	0.000239	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IRS2—osteoporosis	2.17e-05	0.000239	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.14e-05	0.000235	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LEP—osteoporosis	2.12e-05	0.000234	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ESR1—osteoporosis	2.03e-05	0.000223	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ENO1—osteoporosis	1.98e-05	0.000218	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PSMA2—osteoporosis	1.95e-05	0.000215	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PSMA5—osteoporosis	1.95e-05	0.000215	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.9e-05	0.000208	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.85e-05	0.000204	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—POMC—osteoporosis	1.82e-05	0.000201	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.78e-05	0.000196	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.76e-05	0.000193	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6—osteoporosis	1.66e-05	0.000183	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.58e-05	0.000174	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ADCY5—osteoporosis	1.51e-05	0.000166	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GPX1—osteoporosis	1.51e-05	0.000166	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MTHFR—osteoporosis	1.39e-05	0.000153	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6—osteoporosis	1.34e-05	0.000148	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MYC—osteoporosis	1.31e-05	0.000144	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TGFB1—osteoporosis	1.3e-05	0.000143	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ADCY5—osteoporosis	1.29e-05	0.000142	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GPX1—osteoporosis	1.29e-05	0.000142	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MTHFR—osteoporosis	1.19e-05	0.000131	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—POMC—osteoporosis	1.11e-05	0.000122	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MYC—osteoporosis	1.05e-05	0.000116	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	1.05e-05	0.000116	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6—osteoporosis	9.83e-06	0.000108	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—POMC—osteoporosis	9.52e-06	0.000105	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6—osteoporosis	7.93e-06	8.72e-05	CbGpPWpGaD
